Rafael Holdings, Inc. Class B Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
RFL Company Description
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
RFL Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RFL Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of RFL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RFL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of RFL in WallStreetBets Daily Discussion
RFL News
Recent insights relating to RFL
CNBC Recommendations
Recent picks made for RFL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RFL
Corporate Flights
Flights by private jets registered to RFL
Our Analysis